Concepedia

Andreas Spitzmueller

AS

Statistics

Publications

3

Citations

392

H-Index

3

Active since

2017

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Andreas Spitzmueller is an author at AstraZeneca (United States) specializing in cancer biology, tumor biology, and cancer therapeutics.

Top concepts

Publications per year

2017–2021

3

Publications

3

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Michael P. Menden, Dennis Wang, Mike J. Mason et al. · Nature Communications · 2019 · 350 citations · Full text

Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients

Mark Gustavson, Susanne Haneder, Andreas Spitzmueller et al. · Cancer Research · 2021 · 29 citations

, , +23

Mutually exclusive expression of CD73 and PDL1 in tumors from patients (pt) with NSCLC, gastroesophageal (GE) and urothelial bladder carcinoma (UBC).

Philip Martin, Andreas Spitzmueller, Song Wu et al. · Journal of Clinical Oncology · 2017 · 13 citations

, , +21

Rows per page

1–3 of 3